Model Number VITD TOTAL |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/25/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
The investigation reviewed the customer's qc results.The investigation confirmed there were imprecision and low recoveries with qc results between the end of (b)(6) 2021 and the beginning of (b)(6) 2022.The patient's sample was requested for an investigation, but the customer confirmed no sample was available.For dilution testing, product labeling states, "samples with vitamin d (25-oh) concentrations above the measuring range can be manually diluted with diluent universal or a suitable human serum with a low analyte concentration.The recommended dilution is 1:2.The concentration of the diluted sample must be >30.0 ng/ml (>75.0 nmol/l).After manual dilution, multiply the results by the dilution factor 2.The endogenous analyte concentration of the human serum used for dilution has to be taken into account." the investigation is ongoing.
|
|
Event Description
|
The initial reporter received questionable elecsys vitamin d assay results for one patient tested on a cobas e411 disk.Prior to patient testing, the customer confirmed qc was within the acceptable range.The patient's elecsys vitamin d result was reported outside the laboratory.The patient's physician questioned the reported result as it did not match the patient's history.The customer performed dilution testing and sent the sample to a different laboratory for testing on a vidas analyzer.The patient's initial elecsys vitamin d result was ">70" ng/ml.The patient's repeat elecsys vitamin d result with a 1:3 dilution was 145.6 ng/ml with a data flag.The customer's vitamin d result interpretation was "possible toxicity." the patient's vidas vitamin d result was 86.7 ng/ml.The customer's vitamin d result interpretation was sufficient.The e411 serial number was (b)(4).
|
|
Manufacturer Narrative
|
The investigation reviewed the provided sample pre-analytic details, and the number of tube inversions was insufficient compared to the manufacturer's recommendations, and the sample clotting time was requested but not provided.The investigation reviewed the provided alarm trace and found sample short alarms on (b)(6) 2022.The alarm trace from the date of the event were requested but not provided.Based on the provided information, the investigation did not identify a product problem.The cause of the event could not be determined.
|
|
Search Alerts/Recalls
|